Stocks
Innoviva, Inc.INVA
NASDAQHealthcareBiotechnology$22.03+0.27%
A healthcare royalty company that derives the majority of its revenue from partnered respiratory therapies originally developed with GlaxoSmithKline, including Trelegy Ellipta, Breo Ellipta, and Anoro Ellipta. The firm collects long-term royalties on global sales of these medicines and deploys the c...
Market Cap: $1.4B52W Range: $16.52 – $25.15
Congressional Interest in Innoviva, Inc. (INVA)
2 members of Congress have disclosed 3 trades in Innoviva, Inc. (INVA), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
2
Buys
1
Sells
2
Who in Congress Is Trading INVA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-25 | George Whitesides | sell | $250K – $500K |
| 2025-03-24 | George Whitesides | sell | $50K – $100K |